Shoemaker, J. L., Seely, K. A., Reed, R. L., Crow, J. P., & Prather, P. L. (2007). The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
Citação norma ChicagoShoemaker, Jennifer L., Kathryn A. Seely, Ronald L. Reed, John P. Crow, and Paul L. Prather. The CB2 Cannabinoid Agonist AM-1241 Prolongs Survival in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis When Initiated At Symptom Onset. 2007.
Citação norma MLAShoemaker, Jennifer L., et al. The CB2 Cannabinoid Agonist AM-1241 Prolongs Survival in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis When Initiated At Symptom Onset. 2007.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.